Leviticus Cardio successfully completed a 90-day preclinical chronic animal study to evaluate its Coplanar Energy Transfer (CET) technology in combination with a commercial heart pump.
Welcome to Trendlines
We invest in, incubate, and support early-stage, high-promise medical and agricultural technology companies in Israel, a global leader in start-up ingenuity. Read More >
Subscribe to Our Newsletter
Stay in Touch